Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 412

1.

Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.

Guin A, Chatterjee Adhikari M, Chakraborty S, Sinhamahapatra P, Ghosh A.

Semin Arthritis Rheum. 2013 Aug;43(1):48-54. doi: 10.1016/j.semarthrit.2012.12.027. Epub 2013 Feb 12.

PMID:
23415602
2.

Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study.

Chatterjee Adhikari M, Guin A, Chakraborty S, Sinhamahapatra P, Ghosh A.

Semin Arthritis Rheum. 2012 Apr;41(5):669-75. doi: 10.1016/j.semarthrit.2011.08.003. Epub 2011 Oct 28.

PMID:
22035626
3.

Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.

Syngle A, Vohra K, Kaur L, Sharma S.

Scand J Rheumatol. 2009 Jan-Feb;38(1):15-22. doi: 10.1080/03009740802279709.

PMID:
18766955
4.

Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.

Syngle A, Vohra K, Garg N, Kaur L, Chand P.

Int J Rheum Dis. 2012 Feb;15(1):45-55. doi: 10.1111/j.1756-185X.2011.01679.x. Epub 2011 Oct 10.

PMID:
22324946
5.

Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients.

Sidiropoulos PI, Siakka P, Pagonidis K, Raptopoulou A, Kritikos H, Tsetis D, Boumpas DT.

Scand J Rheumatol. 2009 Jan-Feb;38(1):6-10. doi: 10.1080/03009740802363768.

PMID:
18991190
6.

Impaired brachial artery flow-mediated dilation and increased carotid intima-media thickness in rheumatoid arthritis patients.

Fan CY, Zhang ZY, Mei YF, Wu CJ, Shen BZ.

Chin Med J (Engl). 2012 Mar;125(5):832-7.

PMID:
22490583
7.

Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.

Kerekes G, Soltész P, Szucs G, Szamosi S, Dér H, Szabó Z, Csáthy L, Váncsa A, Szodoray P, Szegedi G, Szekanecz Z.

Isr Med Assoc J. 2011 Mar;13(3):147-52.

8.

Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis -- a randomized trial.

Tam LS, Shang Q, Li EK, Wang S, Li RJ, Lee KL, Leung YY, Ying KY, Yim CW, Kun EW, Leung MH, Li M, Li TK, Zhu TY, Chui RK, Tseung L, Yu SL, Kuan WP, Yu CM.

J Rheumatol. 2012 Dec;39(12):2267-75. doi: 10.3899/jrheum.120541. Epub 2012 Sep 15.

PMID:
22984272
9.

Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis.

Turiel M, Tomasoni L, Sitia S, Cicala S, Gianturco L, Ricci C, Atzeni F, De Gennaro Colonna V, Longhi M, Sarzi-Puttini P.

Cardiovasc Ther. 2010 Oct;28(5):e53-64. doi: 10.1111/j.1755-5922.2009.00119.x.

PMID:
20337633
10.

The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.

Aletaha D, Smolen JS.

Rheumatology (Oxford). 2002 Dec;41(12):1367-74.

PMID:
12468815
11.

Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.

Kerekes G, Szekanecz Z, Dér H, Sándor Z, Lakos G, Muszbek L, Csipö I, Sipka S, Seres I, Paragh G, Kappelmayer J, Szomják E, Veres K, Szegedi G, Shoenfeld Y, Soltész P.

J Rheumatol. 2008 Mar;35(3):398-406. Epub 2008 Jan 15.

PMID:
18203326
12.

Clinical significance of brachial flow-mediated dilation in patients with rheumatoid arthritis.

Watanabe T, Takemura M, Sato M, Matsunami H, Seishima M, Shimizu K, Matsuoka T.

Int J Rheum Dis. 2014 Jan;17(1):26-33. doi: 10.1111/1756-185x.12021. Epub 2013 Jan 18.

PMID:
24472263
13.

Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy.

Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Gomez-Acebo I, Testa A, Garcia-Porrua C, Sanchez-Andrade A, Llorca J, González-Gay MA.

Mediators Inflamm. 2012;2012:674265. doi: 10.1155/2012/674265. Epub 2012 Jul 31.

14.
15.
16.

Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Hyrich KL, Watson KD, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register.

Rheumatology (Oxford). 2006 Dec;45(12):1558-65. Epub 2006 May 16.

PMID:
16705046
17.

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis.

Kerekes G, Soltész P, Dér H, Veres K, Szabó Z, Végvári A, Szegedi G, Shoenfeld Y, Szekanecz Z.

Clin Rheumatol. 2009 Jun;28(6):705-10. doi: 10.1007/s10067-009-1095-1. Epub 2009 Mar 25.

PMID:
19319624
18.

Serum soluble receptor for advanced glycation end products levels and aortic augmentation index in early rheumatoid arthritis--a prospective study.

Tam LS, Shang Q, Li EK, Wong S, Li RJ, Lee KL, Leung YY, Ying KY, Yim CW, Kun EW, Leung MH, Li M, Li TK, Zhu TY, Chui RK, Tseung L, Yu SL, Kuan WP, Yu CM.

Semin Arthritis Rheum. 2013 Feb;42(4):333-45. doi: 10.1016/j.semarthrit.2012.07.002. Epub 2012 Aug 22.

PMID:
22920235
19.
20.

Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima-media thickness: Associations in rheumatoid arthritis patients.

Temiz A, Gökmen F, Gazi E, Akbal A, Barutçu A, Bekler A, Altun B, Tan YZ, Güneş F, Şen H.

Herz. 2015 May;40 Suppl 3:217-24. doi: 10.1007/s00059-014-4140-z. Epub 2014 Aug 21.

PMID:
25139185

Supplemental Content

Support Center